Advertisement
Screener

Tempest Therapeutics, Inc. (TPST) Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

Tempest Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

Tempest Therapeutics, Inc. (TPST) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $70.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-13

  • Tempest Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$335.00K.
  • Tempest Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $405.00K, a 66.67% decline year-over-year.
  • Tempest Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$372.00K, a 122.85% decline year-over-year.
  • Tempest Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $134.00K.
  • Tempest Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$3.40M, a 367.40% decline from fiscal 2024.
  • Tempest Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $1.27M.
  • Tempest Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$992.00K, a 158.05% decline from fiscal 2022.
  • Tempest Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $1.71M, a 136.38% increase from fiscal 2021.
Period endIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filedIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filedIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filedIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filedIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 15 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 18 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 21 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 24 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 27 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 30 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 33 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 36 month
2026-06-30-$335.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$70.00K
10-Q · filed 2026-08-13
-$302.00K
derived: sum of 3 quarters · filed 2026-08-13
-$168.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$405.00K
10-Q · filed 2026-05-14
$33.00K
derived: sum of 2 quarters · filed 2026-05-14
$167.00K
derived: sum of 3 quarters · filed 2026-05-14
-$4.21M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$372.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
-$238.00K
derived: sum of 2 quarters · filed 2026-03-30
-$4.62M
derived: sum of 3 quarters · filed 2026-08-13
-$3.40M
10-K · filed 2026-03-30
2025-09-30$134.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$4.25M
derived: sum of 2 quarters · filed 2026-08-13
-$3.03M
10-Q · filed 2025-11-05
-$1.40M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$4.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$3.17M
10-Q · filed 2026-08-13
-$1.54M
derived: sum of 3 quarters · filed 2026-08-13
-$2.19M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$1.22M
10-Q · filed 2026-05-14
$2.84M
derived: sum of 2 quarters · filed 2026-05-14
$2.19M
derived: sum of 3 quarters · filed 2026-05-14
$3.49M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$1.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$977.00K
derived: sum of 2 quarters · filed 2026-03-30
$2.27M
derived: sum of 3 quarters · filed 2026-03-30
$1.27M
10-K · filed 2026-03-30
2024-09-30-$651.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$646.00K
derived: sum of 2 quarters · filed 2025-11-05
-$355.00K
10-Q · filed 2025-11-05
-$66.00K
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30$1.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$296.00K
10-Q · filed 2025-08-11
$585.00K
derived: sum of 3 quarters · filed 2025-08-11
$235.00K
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31-$1.00M
10-Q · filed 2025-05-13
-$712.00K
derived: sum of 2 quarters · filed 2025-05-13
-$1.06M
derived: sum of 3 quarters · filed 2025-05-13
-$779.00K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$289.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$61.00K
derived: sum of 2 quarters · filed 2025-03-27
$222.00K
derived: sum of 3 quarters · filed 2025-03-27
-$992.00K
10-K · filed 2025-03-27
2023-09-30-$350.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$67.00K
derived: sum of 2 quarters · filed 2024-11-12
-$1.28M
10-Q · filed 2024-11-12
-$518.00K
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$283.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$931.00K
10-Q · filed 2024-08-08
-$168.00K
derived: sum of 3 quarters · filed 2024-08-08
$455.00K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$1.21M
10-Q · filed 2024-05-09
-$451.00K
derived: sum of 2 quarters · filed 2024-05-09
$172.00K
derived: sum of 3 quarters · filed 2024-05-09
-$568.00K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$763.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
$1.39M
derived: sum of 2 quarters · filed 2024-03-19
$646.00K
derived: sum of 3 quarters · filed 2024-03-19
$1.71M
10-K · filed 2024-03-19
2022-09-30$623.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$117.00K
derived: sum of 2 quarters · filed 2023-11-08
$946.00K
10-Q · filed 2023-11-08
$2.03M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$740.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$323.00K
10-Q · filed 2023-08-10
$1.41M
derived: sum of 3 quarters · filed 2023-08-10
$2.24M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$1.06M
10-Q · filed 2023-05-10
$2.15M
derived: sum of 2 quarters · filed 2023-05-10
$2.98M
derived: sum of 3 quarters · filed 2023-05-10
$2.27M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$1.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
$1.92M
derived: sum of 2 quarters · filed 2023-03-22
$1.20M
derived: sum of 3 quarters · filed 2023-03-22
$723.00K
10-K · filed 2023-03-22
2021-09-30$834.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$117.00K
derived: sum of 2 quarters · filed 2022-11-08
-$363.00K
10-Q · filed 2022-11-08
-$1.20M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$717.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
-$1.20M
10-Q · filed 2022-08-15
-$2.03M
derived: sum of 3 quarters · filed 2022-08-15
-$777.00K
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$480.00K
10-Q · filed 2022-05-13
-$2.70M
10-Q · filed 2021-05-13
-$1.32M
derived: sum of 2 quarters · filed 2022-05-13
-$60.00K
derived: sum of 3 quarters · filed 2022-05-13
$1.57M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$836.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$420.00K
derived: sum of 2 quarters · filed 2022-03-29
$2.05M
derived: sum of 3 quarters · filed 2022-03-29
-$205.00K
10-K · filed 2022-03-29
-$3.56M
10-K · filed 2021-03-29
2020-09-30$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$2.89M
derived: sum of 2 quarters · filed 2021-11-10
$631.00K
10-Q · filed 2021-11-10
-$4.80M
10-Q · filed 2020-11-09
$2.12M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$1.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$625.00K
10-Q · filed 2021-08-12
-$1.59M
10-Q · filed 2020-08-10
$860.00K
derived: sum of 3 quarters · filed 2021-08-12
$548.00K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$2.25M
10-Q · filed 2021-05-13
-$770.00K
derived: sum of 2 quarters · filed 2021-05-13
-$1.08M
derived: sum of 3 quarters · filed 2021-05-13
-$683.00K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29
$1.17M
derived: sum of 2 quarters · filed 2021-03-29
$1.57M
derived: sum of 3 quarters · filed 2021-03-29
$281.00K
10-K · filed 2021-03-29
2019-09-30-$312.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$87.00K
derived: sum of 2 quarters · filed 2020-11-09
-$1.20M
10-Q · filed 2020-11-09
$168.00K
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$399.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$892.00K
10-Q · filed 2020-08-10
$480.00K
derived: sum of 3 quarters · filed 2020-08-10
$1.90M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31-$1.29M
10-Q · filed 2020-05-08
$81.00K
derived: sum of 2 quarters · filed 2020-05-08
$1.50M
derived: sum of 3 quarters · filed 2020-05-08
$2.37M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
$2.79M
derived: sum of 2 quarters · filed 2020-03-11
$3.66M
derived: sum of 3 quarters · filed 2020-03-11
$3.24M
10-K · filed 2020-03-11
2018-09-30$1.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$2.29M
derived: sum of 2 quarters · filed 2019-11-13
$1.87M
10-Q · filed 2019-11-13
-$2.59M
10-Q · filed 2018-11-09
$5.91M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$869.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
$446.00K
10-Q · filed 2019-08-12
-$1.75M
10-Q · filed 2018-08-09
$4.49M
derived: sum of 3 quarters · filed 2019-08-12
$2.48M
derived: sum of 4 quarters · filed 2019-08-12
2018-03-31-$423.00K
10-Q · filed 2019-05-15
-$1.64M
10-Q · filed 2018-05-03
$3.62M
derived: sum of 2 quarters · filed 2019-05-15
$1.61M
derived: sum of 3 quarters · filed 2019-05-15
$1.42M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$4.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$2.03M
derived: sum of 2 quarters · filed 2019-04-01
$1.84M
derived: sum of 3 quarters · filed 2019-04-01
-$1.39M
10-K · filed 2019-04-01
-$5.75M
10-K · filed 2018-03-15
2017-09-30-$2.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$2.20M
derived: sum of 2 quarters · filed 2018-11-09
-$5.44M
10-Q · filed 2018-11-09
-$1.81M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30-$186.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$3.42M
10-Q · filed 2018-08-09
$200.00K
derived: sum of 3 quarters · filed 2018-08-09
$176.00K
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$3.24M
10-Q · filed 2018-05-03
$386.00K
derived: sum of 2 quarters · filed 2018-05-03
$362.00K
derived: sum of 3 quarters · filed 2018-05-03
$849.00K
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31$3.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$3.60M
derived: sum of 2 quarters · filed 2018-03-15
$4.09M
derived: sum of 3 quarters · filed 2018-03-15
$4.81M
10-K · filed 2018-03-15
2016-09-30-$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$463.00K
derived: sum of 2 quarters · filed 2017-11-02
$1.18M
10-Q · filed 2017-11-02
$3.38M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$487.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$1.21M
10-Q · filed 2017-08-03
$3.41M
derived: sum of 3 quarters · filed 2018-03-15
$4.74M
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31$721.00K
10-Q · filed 2017-05-09
$2.92M
derived: sum of 2 quarters · filed 2018-03-15
$4.25M
derived: sum of 3 quarters · filed 2018-03-15
$5.00M
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$2.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$3.53M
derived: sum of 2 quarters · filed 2018-03-15
$4.28M
derived: sum of 3 quarters · filed 2018-03-15
$752.00K
10-K · filed 2018-03-15
2015-09-30$1.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$2.08M
derived: sum of 2 quarters · filed 2016-11-03
-$1.45M
10-Q · filed 2016-11-03
-$769.00K
derived: sum of 4 quarters · filed 2017-03-02
2015-06-30$750.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$2.78M
10-Q · filed 2016-08-04
-$2.10M
derived: sum of 3 quarters · filed 2017-03-02
-$2.01M
derived: sum of 4 quarters · filed 2017-03-02
2015-03-31-$3.53M
10-Q · filed 2016-05-05
-$2.85M
derived: sum of 2 quarters · filed 2017-03-02
-$2.76M
derived: sum of 3 quarters · filed 2017-03-02
-$1.46M
derived: sum of 4 quarters · filed 2017-03-02
2014-12-31$680.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02
$767.00K
derived: sum of 2 quarters · filed 2017-03-02
$2.07M
derived: sum of 3 quarters · filed 2017-03-02
$2.30M
10-K · filed 2017-03-02
2014-09-30$87.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$1.39M
derived: sum of 2 quarters · filed 2015-11-05
$1.62M
10-Q · filed 2015-11-05
$4.38M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$1.53M
10-Q · filed 2015-08-10
$4.29M
derived: sum of 3 quarters · filed 2016-02-26
$4.11M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$228.00K
10-Q · filed 2015-05-11
$2.99M
derived: sum of 2 quarters · filed 2016-02-26
$2.81M
derived: sum of 3 quarters · filed 2016-02-26
$3.26M
derived: sum of 4 quarters · filed 2016-02-26
$4.42M
10-Q · filed 2014-05-08
2013-12-31$2.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$2.58M
derived: sum of 2 quarters · filed 2016-02-26
$3.03M
derived: sum of 3 quarters · filed 2016-02-26
$2.97M
10-K · filed 2016-02-26
$4.19M
10-K · filed 2014-02-27
2013-09-30-$181.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$273.00K
derived: sum of 2 quarters · filed 2014-11-10
$212.00K
10-Q · filed 2014-11-10
$586.00K
derived: sum of 4 quarters · filed 2015-03-16
$1.43M
10-Q · filed 2013-11-13
2013-06-30$454.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$393.00K
10-Q · filed 2014-08-07
$767.00K
derived: sum of 3 quarters · filed 2015-03-16
$406.00K
derived: sum of 4 quarters · filed 2015-03-16
$1.61M
10-Q · filed 2013-08-13
2013-03-31-$61.00K
10-Q · filed 2014-05-08
$313.00K
derived: sum of 2 quarters · filed 2015-03-16
-$48.00K
derived: sum of 3 quarters · filed 2015-03-16
-$30.00K
derived: sum of 4 quarters · filed 2015-03-16
$1.16M
10-Q · filed 2013-05-15
2012-12-31$374.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
$13.00K
derived: sum of 2 quarters · filed 2015-03-16
$31.00K
derived: sum of 3 quarters · filed 2015-03-16
$733.00K
10-K · filed 2015-03-16
$1.22M
10-K · filed 2013-02-25
2012-09-30-$361.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
-$343.00K
derived: sum of 2 quarters · filed 2013-11-13
$359.00K
10-Q · filed 2013-11-13
$845.00K
10-Q · filed 2012-11-13
2012-06-30$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
$720.00K
10-Q · filed 2013-08-13
$1.21M
10-Q · filed 2012-08-14
2012-03-31$702.00K
10-Q · filed 2013-05-15
2011-12-31$486.00K
10-K · filed 2014-02-27
2011-09-30$51.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-13
$455.00K
10-Q · filed 2012-11-13
2011-06-30$404.00K
10-Q · filed 2012-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
BIOVIE INC. (BIVI)United States$0.012B
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B